DOI: https://doi.org/10.26641/2307-0404.2018.1(part2).126931

Adherence to treatment of patients with past ischemic stroke.

V. Je. Azarenko, V. A. Potabashniy, V. I. Fesenko, O. V. Knjazjeva

Abstract


The main task of the general practitioner is managing patients with the effects of ischemic stroke. The improvement of patients adherence to treatment in a significant way contributes to successful secondary prevention of ischemic stroke. Adherence to treatment can be determined through various questionnaires, including Morissky-Green. Currently, the adherence to a long-term drug therapy remains insufficient.


Keywords


consequences of ischemic stroke; general practice-family medicine; Morissky-Green scale; secondary prevention; adherence to treatment

References


Kovalenko VM, Kornac'kyj VM. [Diseases of the circulatory systemas a medical and social and socio-po­li­tical problem]. Analitychno-statystychnyjposibnyk. Кyiv. 2014;279. Ukrainian.

Lukina JuV, Marcevich SJu, Kutishenko NP. [Morissky-Greene scale: the pros and cons of universal test, work on mistakes]. Racional'naja farmakoterapija v kardiologii. 2016;12(1):63-65. Russian.

Radchenko GD, Sirenko JuM, Martsovenko ІM. [Adherence to the treatment of patients with arterial hy­pertension and its changes on the background of therapy. Results of open prospective multicenter study]. Uk­rai'n­s'kyj kardiologichnyj zhurnal. 2010;3:44-57. Ukrainian.

Suslina ZA, Fonjakin AV,Geraskina LA.[Ische­mic stroke and heart: from pathogenesis to prevention]. Klinich. farmakol. i terapija. 2003;5:47-51. Russian.

Shandalin VA, Fonjakin AV,Geraskina LA.[Se­condary prevention of ischemic stroke: from recom­mendations to real clinical practice]. Zhurnal nevrologii, nejropsihiatrii i psihosomatiki. 2012;2:35-41. Russian.

Chobian AV. The Hypertension Paradox – more uncontrolled disease despite improved therapy. N. Engl. J. Med. 2009;361(15):15-16.

Global Burden of Disease Study 2016 (GBD 2016) Data Resources. Available from: ghdx.health­data.org/gbd-2016.

Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack. A guideline for healthсare pro­fessionals from the American heart association. American stroke association. Stroke. 2011;42:227-76.

Jamison J, et al. Barriers and facilitators to adhe­rence to secondary stroke prevention medications afters troke: analysis of survivors and caregivers views from an online stroke forum. BMJ Open 2017;7:e016814. doi: 10.1136/bmjopen-2017-01681

Haynes RB, Teylor DW, Sackett DL. Compliance in healthcare. Baltimor: TheJohnsHopkinsUniversityPress; 1979.

Jamison J, Graffy J, Mullis R, MantJ, Sutton S. Barriers to medication adherence for the secondary pre­vention of stroke: a qualitative interview study in primary care. Br J Gen Pract. 2016;66(649):e568-76. Published online 2016 May 24. doi: 10.3399/bjgp16X685609

Lago A,·Tembl JI,·Pareja A, Ponz A,·Ferrer JM, Vallés J, Santos MT. Adherence to aspirin in secondary prevention of ischemic stroke. Cerebrovasc Dis 2006;21:353-6. https://doi.org/10.1159/000091542

Kulkarni SP, Alexander KP, Lytleetal B. Long-Term adherence with cardiovascular drug regimens. Am. Heart J. 2006;151(1):185-91.

MoriskyDE, Ang A, Krousel-Wood M, Harry J. Ward. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-54.

Sabate E. Adherence to long-term therapies: evi­dence for action.Geneva: WHO; 2003.

Simpson E, Eurich DT, Majumdaretal SR. A meta-analysis of the association between adherence to drugtherapy and mortality. BMJ. 2006;333:15.


GOST Style Citations


  1. Коваленко В.М. Хвороби системи кровообігу як медико-соціальна і суспільно-політична проблема: Аналітично – статистичний посібник / В.М. Кова­ленко, В.М. Корнацький. – Київ, 2014. – 279 с.
  2. Лукина Ю.В. Шкала Мориски-Грина: плюсы и минусы универсального теста, работа над ошибками / Ю.В. Лукина, Н.П. Марцевич, Н.П. Кутишенко // Ра­циональная фармакотерапия в кардиологии.- 2016. - № 12 (1). – С. 63-65.
  3. Радченко Г.Д. Прихильність до лікування хворих з артеріальною гіпертензією та її зміни на тлі терапії. Результати відкритого проспективного бага­тоцентрового дослідження / Г.Д. Радченко, Ю.М. Сі­ренко, І.М. Марцовенко // Укр. кардіол. журнал. – 2010. – № 3. – С. 44-57.
  4. Суслина З.А. Ишемический инсульт и сердце: от патогенеза к профилактике / З.А. Суслина, А.В. Фо­някин, Л.А. Гераскина // Клинич. фармакол. и тера­пия.- 2003.-№5.-С. 47-51.
  5. Шандалин В.А. Вторичная профилактика ише­мического инсульта: от рекомендаций – к реальной клинической практике / В.А. Шандалин, А.В. Фо­някин, Л.А. Гераскина // Журнал неврологии, нейро­психиатрии и психосоматики. - 2012.- № 2. - C. 35-41.
  6. Adherence to aspirin in secondary prevention of ischemic stroke / A. Lago,·J.I. Tembl,·A. Pareja, A. Ponz [et al.] // Cerebrovasc Dis. – 2006. – Vol. 21. – P. 353-356. https://doi.org/10.1159/000091542
  7. Barriers to medication adherence for the secon­dary prevention of stroke: a qualitative interview study in pri­mary care / J. Jamison, J. Graffy, R. Mullis, J. Mant, S. Sut­ton // Br. J. Gen. Pract. – 2016. – Vol. 66, N 649. – e568-e576. Published on line 2016 May 24.  doi: 0.3399/bjgp16X685609
  8. Chobian A.V. The Hypertension Paradox – more un­controlled disease despite improved therapy / A.V. Chobian // N. Engl. J. Med. – 2009. – Vol. 361, N 15. – P. 15-16.
  9. Global Burden of Disease Study 2016 (GBD 2016) Data Resources. available at: ghdx.healthdata.org/gbd-2016.
  10. Guidelines for the early management of patients with acute ischemic stroke. A Guideline for Health care Professionals From the American Heart Association / Ame­rican Stroke Association // Stroke. – 2018. Available at http://stroke.ahajournals.org. doi: 10.1161/STR.0000000000000158
  11. Haynes R.B. Compliance in health care / R.B. Hay­nes, D.W. Teylor, D.L. Sackett / Baltimor: The Johns Hopkins University Press, 1979.
  12. Jamison J. Barriers and facilitators to adherence to secondary stroke prevention medications after stroke: analysis of survivors and caregivers views from an on line stroke forum / J. Jamison // BMJ Open.-2017. – N 7. - e016814. doi:10.1136/bmjopen-2017-016814
  13. Kulkarni S.P. Long-Term adherence with cardio­vascular drug regimens / S.P. Kulkarni, K.P. Alexander, B. Lytleetal / Am. Heart J. – 2006. – Vol. 151, N 1. – P. 185-191.
  14. Predictive validity of a medication adherence measure in an outpatient setting / D.E. Mo­risky, A. Ang, M. Krousel-Wood, Harry J. Ward. // J. Clin Hy­pertens (Greenwich). – 2008. – Vol. 10, N 5. – P. 348-354.
  15. Sabate E. Adherencetolong-termtherapies: evi­den­cefo­raction / E. Sabate. – Geneva: WHO, 2003.
  16. Simpson E. A meta-analysis of the association between adherence to drug therapy and mortality / E. Simpson, D.T. Eurich, S.R. Majumdaretal // BMJ. - 2006. - Vol. 333. – P. 15-18.




 

This work is licensed under a Creative Commons Attribution 4.0 International License